Industrial Purity 3-Amino-4-(Trifluoromethoxy)Bromobenzene COA Specs and Bulk Supply Standards
- Critical CAS Verification: Ensure all batches match CAS 886762-08-9 with molecular formula C7H5BrF3NO.
- Purity Thresholds: Industrial grades must exceed 98% purity with defined limits on regioisomers and halogenated impurities.
- Documentation: Valid COA documentation should include HPLC chromatograms, NMR spectra, and residual solvent analysis.
In the realm of advanced organic synthesis, particularly within the pharmaceutical and agrochemical sectors, the reliability of fluorinated building blocks is paramount. 3-Amino-4-(trifluoromethoxy)bromobenzene serves as a critical intermediate for constructing complex molecular architectures containing trifluoromethoxy groups. These groups are increasingly valued for their metabolic stability and lipophilicity in drug design. However, securing material that meets rigorous industrial purity standards requires a deep understanding of chemical specifications and supplier capabilities.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. emphasizes the importance of transparent quality assurance protocols. When evaluating this chemical, procurement specialists must look beyond basic catalog data and scrutinize the Certificate of Analysis (COA) for specific impurity profiles that could affect downstream reaction yields.
Understanding Assay Specifications and Impurities
The standard laboratory grade for this compound is often listed at 98%, but bulk industrial applications frequently demand tighter controls. The molecular weight of 256.02 g/mol and the specific arrangement of the bromine and trifluoromethoxy groups on the aniline ring create unique challenges during purification. The primary concern in the manufacturing process is the potential presence of regioisomers, such as 5-Bromo-2-(trifluoromethoxy)aniline, or incomplete halogenation byproducts.
High-performance liquid chromatography (HPLC) is the standard method for quantifying the main assay. A robust COA will specify the column type, mobile phase composition, and detection wavelength used. For this specific benzene derivative, UV detection at 254 nm is common. However, gas chromatography (GC) may also be employed to assess volatile impurities. Buyers should ensure that the sum of impurities does not exceed 2.0%, with individual unknown impurities capped at 0.10%.
Furthermore, residual solvents from the crystallization or extraction steps must comply with ICH Q3C guidelines. Common solvents like ethyl acetate, hexane, or dichloromethane should be quantified via headspace GC. Failure to control these residuals can impact the safety and efficacy of the final active pharmaceutical ingredient (API).
Verifying Supplier COA Documentation
A comprehensive COA is the cornerstone of quality verification. It is not merely a statement of purity but a detailed report of the analytical methods employed. When sourcing high-purity 3-Amino-4-(trifluoromethoxy)bromobenzene, buyers should request a COA that includes batch-specific data rather than a generic template. Key elements to verify include the batch number, manufacturing date, and retest date.
The physical appearance should also be documented. Typically, this compound presents as a solid, ranging from off-white to light yellow, depending on the level of oxidation or trace impurities. Any significant deviation in color can indicate degradation or contamination. Additionally, the COA should confirm the identity of the substance through spectral data matching, such as Infrared (IR) spectroscopy or Mass Spectrometry (MS).
For large-scale procurement, consistency between batches is as critical as the purity of a single batch. A reliable supplier will provide historical data showing the stability of the synthesis route over time. This ensures that your production line does not face unexpected variations in reaction kinetics due to subtle changes in the starting material quality.
Quality Assurance Testing Methods
To guarantee the integrity of 5-Bromo-2-(trifluoromethoxy)benzenamine derivatives, multiple orthogonal analytical techniques should be utilized. While HPLC provides purity data, Nuclear Magnetic Resonance (NMR) spectroscopy is essential for structural confirmation. Proton NMR (1H-NMR) will reveal the characteristic splitting patterns of the aromatic protons, confirming the substitution pattern on the benzene ring.
Fluorine NMR (19F-NMR) is particularly useful for this molecule due to the presence of the trifluoromethoxy group. It can detect fluorine-containing impurities that might be invisible to UV detection. Furthermore, elemental analysis (CHN) should align with the theoretical values for C7H5BrF3NO. A deviation of more than 0.4% from theoretical values often suggests the presence of solvates or significant inorganic salts.
Heavy metal testing is another critical component of the QA process, especially for pharmaceutical intermediates. Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is the preferred method for detecting trace metals like palladium, which may remain from catalytic steps in the synthesis route. Ensuring these levels are below ppm thresholds is vital for regulatory compliance.
Technical Specifications Table
The following table outlines the critical technical parameters that should appear on a compliant COA for this intermediate.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 886762-08-9 | Registry Verification |
| Molecular Formula | C7H5BrF3NO | Calculated |
| Molecular Weight | 256.02 g/mol | Calculated |
| Purity (HPLC Area %) | ≥ 98.0% | HPLC-UV |
| Appearance | Off-white to Light Yellow Solid | Visual Inspection |
| Loss on Drying | ≤ 0.5% | Karl Fischer / LOD |
| Residual Solvents | Compliant with ICH Q3C | Headspace GC |
Bulk Procurement and Supply Chain Considerations
Securing a stable supply chain for fluorinated intermediates requires partnering with a manufacturer capable of scaling production without compromising quality. The bulk price is often influenced by the cost of raw materials, such as trifluoromethoxy precursors and brominating agents, as well as the complexity of the purification steps. Manufacturers who optimize their manufacturing process for yield and waste reduction can offer more competitive pricing while maintaining high standards.
Lead times and packaging are also crucial factors. Industrial quantities should be packaged in moisture-proof containers, such as double-lined drums or foil bags within cartons, to prevent hydrolysis or oxidation during transit. Proper storage conditions, typically in a cool, dry place away from light, must be maintained to preserve the chemical stability of the amino group.
For companies requiring consistent supply for long-term projects, NINGBO INNO PHARMCHEM CO.,LTD. offers dedicated production lines and custom synthesis capabilities. By prioritizing technical excellence and regulatory compliance, we ensure that every batch of 5-Bromo-2-(trifluoromethoxy)aniline meets the stringent requirements of modern drug discovery and development.
In conclusion, verifying the quality of this bromobenzene derivative involves a multi-faceted approach encompassing detailed COA review, advanced spectral analysis, and supply chain validation. By adhering to these standards, pharmaceutical and chemical companies can mitigate risk and ensure the success of their synthesis campaigns.